New hope for rare, deadly skin cancer
NCT ID NCT06673628
Summary
This study is testing a new combination of two existing cancer drugs to treat a rare and aggressive skin cancer called cutaneous angiosarcoma. It will enroll 38 patients in Japan whose cancer cannot be removed by surgery. The goal is to see if the drug combo is more effective at shrinking tumors than current standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOSARCOMA OF SKIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Keio University Hospital
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nagoya City University Hospital
RECRUITINGNagoya, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Cancer Center Hospital
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Cancer Center Hospital East
RECRUITINGKashiwa, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Kyoto Prefectural University of Medicine
RECRUITINGKyoto, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.